Hoffman Michael B — SEC insider filings

SEC reporting owner CIK 1290208. 22 insider filings on record with FilingPulse; latest filed 2026-11-06.

Transaction summary — filings shown

Covers all 22 filings on record, filed 2020-08-31 to 2026-11-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Annovis Bio, Inc. (ANVS)Director2019 legs · 6,924,154 sh · $9,256,876—24
Onconova Therapeutics, Inc. (ONTX)Director1—2 legs · 184,368 sh · $50,130—
Translational Development Acquisition Corp. (TDAC)Chairman and CEO, Director1——1

Insider filings — Hoffman Michael B

FiledFormIssuerReported transactionsSource
2026-11-064Annovis Bio, Inc. (ANVS)Purchase (P): 5,000,000 @ $1 · Purchase (P): 5,000,000 (derivative) @ $0EDGAR
2026-05-294Translational Development Acquisition Corp. (TDAC)Purchase (P): 53,395 (derivative) @ $0.79EDGAR
2026-05-214Annovis Bio, Inc. (ANVS)Purchase (P): 2,562 @ $1.75 · Purchase (P): 18,849 @ $1.80 · Purchase (P): 54,933 @ $1.90EDGAR
2026-04-034Annovis Bio, Inc. (ANVS)Purchase (P): 713,800 @ $2.10EDGAR
2025-12-084Annovis Bio, Inc. (ANVS)Purchase (P): 30,000 @ $4.34 · Purchase (P): 15,000 @ $4.24EDGAR
2025-11-254/AAnnovis Bio, Inc. (ANVS)Purchase (P): 1,489 @ $4.13 · Purchase (P): 9,200 @ $3.85 · Purchase (P): 415 @ $4.14 · Purchase (P): 28,096 @ $4.15EDGAR
2025-11-254Annovis Bio, Inc. (ANVS)Purchase (P): 1,489 @ $4.13 · Purchase (P): 9,200 @ $3.85 · Purchase (P): 415 @ $4.14 · Purchase (P): 28,096 @ $4.15EDGAR
2025-11-214Annovis Bio, Inc. (ANVS)Purchase (P): 10,000 @ $3.49 · Purchase (P): 10,000 @ $3.50EDGAR
2025-11-184Annovis Bio, Inc. (ANVS)Purchase (P): 15,000 @ $2.11EDGAR
2025-11-124Annovis Bio, Inc. (ANVS)Purchase (P): 975,610 @ $2.05EDGAR
2025-09-034Annovis Bio, Inc. (ANVS)Grant/award (A): 5,000 @ $2.28 · Grant/award (A): 5,000 @ $2.29 · Grant/award (A): 5,000 @ $2.30EDGAR
2025-08-204Annovis Bio, Inc. (ANVS)Grant/award (A): 6,717 @ $2.60 · Grant/award (A): 5,283 @ $2.59 · Grant/award (A): 5,545 @ $2.58 · Grant/award (A): 1,100 @ $2.57EDGAR
2025-06-164Annovis Bio, Inc. (ANVS)Grant/award (A): 25,000 @ $2.80 · Grant/award (A): 1 @ $2.83EDGAR
2025-06-024Annovis Bio, Inc. (ANVS)Grant/award (A): 5,000 @ $2.43EDGAR
2024-07-034Annovis Bio, Inc. (ANVS)Grant/award (A): 29,600 (derivative) @ $0EDGAR
2023-11-224/AAnnovis Bio, Inc. (ANVS)Grant/award (A): 163,880 @ $6.10EDGAR
2023-11-214Annovis Bio, Inc. (ANVS)Grant/award (A): 164,745 @ $6.07EDGAR
2023-04-114Annovis Bio, Inc. (ANVS)Grant/award (A): 59,477 @ $12.61EDGAR
2023-01-204Annovis Bio, Inc. (ANVS)Grant/award (A): 6,820 (derivative) @ $0EDGAR
2022-01-054Annovis Bio, Inc. (ANVS)Option exercise (M): 30,000 @ $4.39 · Tax withholding (F): 6,658 @ $19.78 · Option exercise (M): 7,142 @ $0.25 · Tax withholding (F): 90 @ $19.78 · Grant/award (A): 9,000 (derivative) @ $0 · Option exercise (M): 30,000 (derivative) @ $0 · +1 moreEDGAR
2021-07-094Annovis Bio, Inc. (ANVS)Grant/award (A): 4,500 (derivative) @ $0EDGAR
2020-08-314Onconova Therapeutics, Inc. (ONTX)Sale (S): 182,492 @ $0.27 · Sale (S): 1,876 @ $0.27EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1290208 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs